Literature DB >> 22740929

Monosomy of chromosome 8 could be considered as a primary preneoplastic event in breast cancer: A preliminary study.

Fabiola A García Parra-Pérez1, Angel Zavala-Pompa, Javier Pacheco-Calleros, Elva I Cortés-Gutiérrez, Ricardo M Cerda-Flores, Sandra Lara-Miranda, Martha I Dávila-Rodríguez.   

Abstract

This pilot study analyzed and compared the presence of chromosome 8 aneusomy in Mexican women with breast cancer and adjacent, intraductal, proliferative lesions. To determine the chromosome 8 copy number, we performed fluorescence in situ hybridization in nine patients (1800 cells) who underwent mastectomy. We selected two tissue samples from each patient, one corresponding to the invasive ductal carcinoma (IDC) and the other adjacent to the intraductal proliferative lesion (IPL). Breast tissue from 17 autopsy samples (1700 cells) was used as a control. The number of cells with monosomy, disomy and polysomy per subject and type of tissue were compared among the three groups of tissue with the RxC statistical software package using 50,000 total replicates. Chromosome 8 aneusomy was found in 66 and 67% of cells from the IDC and IPL samples, respectively. Monosomy was detected significantly more frequently in IPL compared with IDC samples (49.11 vs. 27.11%; p=0.0000), whereas polysomy was significantly more frequent in IDC compared with IPL samples (40.11 vs. 16.99%; p=0.00000). Control cells showed 92.3% disomy. These findings suggest that polysomy of chromosome 8 is more frequently observed in IDC and that monosomy is more frequent in tissue of IPL. Therefore, monosomy may be considered as a primary preneoplastic event. Future studies should be performed to increase the amount of breast tissue with ductal proliferative changes and with cancer, in order to support the results of this pilot study.

Entities:  

Year:  2011        PMID: 22740929      PMCID: PMC3362558          DOI: 10.3892/ol.2011.484

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

1.  Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer.

Authors:  S Roka; M Fiegl; N Zojer; M Filipits; R Schuster; B Steiner; R Jakesz; H Huber; J Drach
Journal:  Breast Cancer Res Treat       Date:  1998-03       Impact factor: 4.872

2.  Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.

Authors:  D W Visscher; T L Wallis; J D Crissman
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

3.  Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer.

Authors:  A Afify; K I Bland; H F Mark
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer.

Authors:  Sehwan Han; Kyeongmee Park; Eunah Shin; Hyun-Jung Kim; Jung Yeon Kim; Ji Young Kim; Geumhee Gwak
Journal:  Oncol Rep       Date:  2010-07       Impact factor: 3.906

5.  Loss of heterozygosity in normal tissue adjacent to breast carcinomas.

Authors:  G Deng; Y Lu; G Zlotnikov; A D Thor; H S Smith
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

6.  Abnormal chromosome 8 copy number in stage I to stage IV breast cancer studied by fluorescence in situ hybridization.

Authors:  H F Mark; W Taylor; S Brown; M Samy; C L Sun; K Santoro; K I Bland
Journal:  Cancer Genet Cytogenet       Date:  1999-01-01

Review 7.  Genetic alterations in breast cancer.

Authors:  I Bièche; R Lidereau
Journal:  Genes Chromosomes Cancer       Date:  1995-12       Impact factor: 5.006

8.  Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis.

Authors:  M C Cummings; M Aubele; A Mattis; D Purdie; P Hutzler; H Höfler; M Werner
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

9.  Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma.

Authors:  M Aubele; M Cummings; A Walsch; H Zitzelsberger; J Nährig; H Höfler; M Werner
Journal:  Anal Cell Pathol       Date:  2000       Impact factor: 2.916

10.  DNA aneuploidy in early breast cancer.

Authors:  G L Ottesen; I J Christensen; J K Larsen; G B Kerndrup; B Hansen; J A Andersen
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.